The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission.
Sarah M BartschCameron M AvelisLindsey AstiDaniel L HertensteinMartial Ndeffo-MbahAlison GalvaniBruce Y LeePublished in: PLoS neglected tropical diseases (2018)
Even when identifying and treating as little as 5% of cases annually, treating Chagas cases in the acute and indeterminate stages reduces transmission and provides economic and health benefits. This supports the need for improved diagnostics and access to safe and effective treatment.
Keyphrases
- trypanosoma cruzi
- end stage renal disease
- healthcare
- chronic kidney disease
- ejection fraction
- newly diagnosed
- public health
- liver failure
- mental health
- peritoneal dialysis
- prognostic factors
- respiratory failure
- patient reported outcomes
- intensive care unit
- risk assessment
- social media
- combination therapy
- acute respiratory distress syndrome
- hepatitis b virus
- human health
- mechanical ventilation
- health promotion